Expert Insights New Year’s Resolutions: Lose Weight & Allocate to GLP-1 ETFs By Cinthia MurphyJanuary 17, 2025
Disruptive Technology Content Hub Disruptive Theme of the Week: Playing Defense By Jane EdmondsonAugust 14, 2024
Innovative ETFs Content Hub Pfizer’s COVID-19 Pill Has Mixed Results for Healthcare ETFs By Max ChenNovember 5, 2021
Equity ETF Content Hub Biotech ETFs Make Gains Tuesday, Despite the J&J Vaccine Pause By Ian YoungApril 13, 2021
Innovative ETFs Content Hub Potential Peanut Allergy Treatment Gives Pharma Company A Boost By Ian YoungSeptember 11, 2019
Beyond Basic Beta Content Hub 8 ETFs to Capture Opportunities in Healthcare Sector By Max ChenAugust 22, 2019
Thematic Investing Content Hub Johnson & Johnson Could Be A Good Bet Despite Opioid Lawsuit By Ian YoungJuly 8, 2019
Innovative ETFs Content Hub AbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFs By Max ChenJune 25, 2019
Equity ETF Content Hub Tom Lydon on CNBC: Can Health Care Cure Itself? By Ben HernandezApril 15, 2019
Beyond Basic Beta Content Hub 4 ETFs to Consider with Big Pharma on the Senate’s Hot Seat By Ben HernandezApril 9, 2019
Equity ETFs Healthcare ETFs Looked Pale on Reports J&J Knew About Asbestos in Baby Powder By Max ChenDecember 14, 2018
